Evidence map›Paper›PMID 23416329›Full record

ArticleJournal of biotechnology2013

Expression analysis of multiple myeloma CD138 negative progenitor cells using single molecule microarray readout.

Jaroslaw Jacak, Harald Schnidar, Leila Muresan, Gerhard Regl, Annemarie Frischauf, Fritz Aberger, Gerhard J Schütz, Jan Hesse

Open access · hybridAbstract read
In one paragraph

Article in Journal of biotechnology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jaroslaw JacakBiophysics Institute, Johannes Kepler University Linz, A-4040 Linz, Austria.
Harald Schnidar
Leila Muresan
Gerhard Regl
Annemarie Frischauf
Fritz Aberger
Gerhard J Schütz
Jan Hesse
University of Salzburg · ATJohannes Kepler University of Linz · ATTU Wien · AT

Funding

Austrian Science Fund FWF Y 250
6 · The paper itself

Abstract

We present a highly sensitive bioanalytical microarray assay that enables the analysis of small genomic sample material. By combining an optimized cDNA purification step with single molecule cDNA detection on the microarray, the platform has improved sensitivity compared to conventional systems, allowing amplification-free determination of expression profiles with as little as 600ng total RNA. Total RNA from cells was reverse transcribed into fluorescently labeled cDNA and purified employing a precipitation method that minimizes loss of cDNA material. The microarray was scanned on a fluorescence chip-reader with single molecule sensitivity. Using the newly developed platform we were able to analyze the RNA expression profile of a subpopulation of rare multiple myeloma CD138 negative progenitor (MM CD138(neg)) cells. The high-sensitivity microarray approach led to the identification of a set of 20 genes differentially expressed in MM CD138(neg) cells. Our work demonstrates the applicability of a straight-forward single-molecule DNA array technology to current topics of molecular and cellular cancer research, which are otherwise difficult to address due to the limited amount of sample material.

Indexed as

Cell Line, TumorGene Expression ProfilingHumansMicroscopy, FluorescenceMultiple MyelomaNeoplastic Stem CellsOligonucleotide Array Sequence AnalysisRNA, MessengerStem CellsSyndecan-1RNA, MessengerSyndecan-1

Identifiers

PMID23416329
PMCPMC3632753
OpenAlexW2080037052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.